CVS Pathology Lecture Notes (L2)
... atherosclerosis – narrowing of the arteries arteriosclerosis – hardening of the vessels arteriolosclerosis – hardening and thicking of walls of smaller arteries (arterioles) Complications 1. calcification 2. ulceration (cholesterol crystals and emboli) 3. thrombosis (obstruction/blocked) 4. haemorrh ...
... atherosclerosis – narrowing of the arteries arteriosclerosis – hardening of the vessels arteriolosclerosis – hardening and thicking of walls of smaller arteries (arterioles) Complications 1. calcification 2. ulceration (cholesterol crystals and emboli) 3. thrombosis (obstruction/blocked) 4. haemorrh ...
Surgical Management of Ischaemic Heart Disease
... • Gives of a Posterior Descending artery branch in approx 70% of patients • 20% of patients the PDA comes of the left circumflex and are hence Left dominant • 10% PDA comes off both and are then Codominant. • Supplies 25% - 35% of the left ventricle and the SA node in 60% of cases (otherwise LCx art ...
... • Gives of a Posterior Descending artery branch in approx 70% of patients • 20% of patients the PDA comes of the left circumflex and are hence Left dominant • 10% PDA comes off both and are then Codominant. • Supplies 25% - 35% of the left ventricle and the SA node in 60% of cases (otherwise LCx art ...
Comparison of a drug-eluting balloon first and then bare metal stent
... Background Since percutaneous coronary intervention (PCI), using balloon angioplasty and bare metal stents (BMS), was introduced, restenosis of a lesion treated percutaneously remains a matter of concern, especially when BMS are used [1,2]. Although the use of drug-eluting stents (DES) has reduced t ...
... Background Since percutaneous coronary intervention (PCI), using balloon angioplasty and bare metal stents (BMS), was introduced, restenosis of a lesion treated percutaneously remains a matter of concern, especially when BMS are used [1,2]. Although the use of drug-eluting stents (DES) has reduced t ...
What is Coronary Artery Disease?
... These drugs are usually started after a heart attack or after a stent is placed, but may also be prescribed in chronic disease to help prevent future events for high risk patients like diabetics. There are several other drugs that are also used to treat CAD. Statins, beta blockers, ace inhibitors, c ...
... These drugs are usually started after a heart attack or after a stent is placed, but may also be prescribed in chronic disease to help prevent future events for high risk patients like diabetics. There are several other drugs that are also used to treat CAD. Statins, beta blockers, ace inhibitors, c ...
Dog heart coronary artery cast - Online Veterinary Anatomy Museum
... paraeonal intez,uentv,iculav' branch ...
... paraeonal intez,uentv,iculav' branch ...
Supplemental Table 1
... Supplemental Table 1. Serious cardiac outcome definitions. a Outcome Death Myocardial Infarction (MI) ...
... Supplemental Table 1. Serious cardiac outcome definitions. a Outcome Death Myocardial Infarction (MI) ...
Overview: Coronary Artery Bypass Grafts (CABG) are surgical
... Since the mid 1980s, left internal mammary artery (LIMA) grafts have largely replaced saphenous vein grafts when bypassing the left anterior descending coronary artery (LAD). With this type of procedure, one end of the LIMA is freed from the chest wall and attached to the LAD beyond the area of obst ...
... Since the mid 1980s, left internal mammary artery (LIMA) grafts have largely replaced saphenous vein grafts when bypassing the left anterior descending coronary artery (LAD). With this type of procedure, one end of the LIMA is freed from the chest wall and attached to the LAD beyond the area of obst ...
4-coronary-heart-disease-1
... called atherosclerosis, or hardening of the arteries. The buildup of fat and calcium inside the arteries is called a ...
... called atherosclerosis, or hardening of the arteries. The buildup of fat and calcium inside the arteries is called a ...
Feasibility, Safety, and Efficacy of a Novel Polymeric Pimecrolimus
... and biocompatibility when stents coated with polymer only, drug only, and 2 drug-polymer formulations were compared with bare-metal stents (BMS). In the phase I clinical trial, 15 patients had successful implantation of pimecrolimus-eluting stents. By 6 months, no patient suffered death, myocardial ...
... and biocompatibility when stents coated with polymer only, drug only, and 2 drug-polymer formulations were compared with bare-metal stents (BMS). In the phase I clinical trial, 15 patients had successful implantation of pimecrolimus-eluting stents. By 6 months, no patient suffered death, myocardial ...
S2006_74.DOC ENDOCARDIAL FIBROELASTOSIS
... ENDOCARDIAL FIBROELASTOSIS AND MITRAL REGURGITATION IN A YOUNG WOMAN H. Bogabathina, P. Manchikalapati, T.J. Wool, J.H. Halanych, K.J Wool. UAB Montgomery Internal Medicine Residency Program; Montgomery AL. Presentation: This is a 33 year old African American lady who presented with exertional dyspn ...
... ENDOCARDIAL FIBROELASTOSIS AND MITRAL REGURGITATION IN A YOUNG WOMAN H. Bogabathina, P. Manchikalapati, T.J. Wool, J.H. Halanych, K.J Wool. UAB Montgomery Internal Medicine Residency Program; Montgomery AL. Presentation: This is a 33 year old African American lady who presented with exertional dyspn ...
Supplemental Content
... Guidelines on myocardial Revascularization. European Heart Journal (2014) 35, 2541–2619. ...
... Guidelines on myocardial Revascularization. European Heart Journal (2014) 35, 2541–2619. ...
coronary artery calcification and its relation to systolic function
... coronary artery calcification and its relation to LV function estimated by MsCT in chronic coronary artery disease. Patients and Methods: Out of 758 persons who were referred to 64 slices MSCT, the total of 156 (age 50 to 69 years, 64% males) in sinus rhythm with chronic coronary artery disease were ...
... coronary artery calcification and its relation to LV function estimated by MsCT in chronic coronary artery disease. Patients and Methods: Out of 758 persons who were referred to 64 slices MSCT, the total of 156 (age 50 to 69 years, 64% males) in sinus rhythm with chronic coronary artery disease were ...
Dr. Deng Xi Wei , MACC Chief Consultant in Cardiology Kiang Wu
... * Those well-known conditions are both acute ...
... * Those well-known conditions are both acute ...
TACSM Abstract - Case Study Case Presentation for Percutaneous
... coronary arteries becoming hardened and narrow which causes a decrease in oxygen-rich blood flow to the heart. Coronary heart disease is usually caused by the build-up of plaque in the arteries. Percutaneous transluminal coronary angioplasty is a procedure in which blocked coronary arteries are open ...
... coronary arteries becoming hardened and narrow which causes a decrease in oxygen-rich blood flow to the heart. Coronary heart disease is usually caused by the build-up of plaque in the arteries. Percutaneous transluminal coronary angioplasty is a procedure in which blocked coronary arteries are open ...
Updates on Endovascular Revascularization for Lower
... Fowkes FG, Rudan D, Rudan I, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet. 2013;382(9901):13291340. Jeffrey L. Anderson, et al; Management of Patients With Peripheral Artery Disease (Comp ...
... Fowkes FG, Rudan D, Rudan I, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet. 2013;382(9901):13291340. Jeffrey L. Anderson, et al; Management of Patients With Peripheral Artery Disease (Comp ...
Ashley Boam - Product Quality Research Institute
... Ashley Boam currently serves as acting Deputy Director of the Office of Pharmaceutical Science in the Center for Drug Evaluation and Research (CDER). Prior to joining CDER, Ashley spent nearly 20 years in the Office of Device Evaluation (ODE) in FDA’s Center for Devices and Radiological Health (CDRH ...
... Ashley Boam currently serves as acting Deputy Director of the Office of Pharmaceutical Science in the Center for Drug Evaluation and Research (CDER). Prior to joining CDER, Ashley spent nearly 20 years in the Office of Device Evaluation (ODE) in FDA’s Center for Devices and Radiological Health (CDRH ...
Coronary Artery Bypass Grafting What is Coronary
... Depending on the number of bypasses needed, the surgery could take from one to four hours. Where do these vessels come from? The two most common vessels used are the Internal Mammary Artery (IMA) situated in the chest and the saphenous vein which is taken from the leg. Occasionally an artery from th ...
... Depending on the number of bypasses needed, the surgery could take from one to four hours. Where do these vessels come from? The two most common vessels used are the Internal Mammary Artery (IMA) situated in the chest and the saphenous vein which is taken from the leg. Occasionally an artery from th ...
Enhancing Vascular Imaging by OCT at the Charité Hospital
... Optical coherence tomography (OCT) was first demonstrated in 1991 for imaging the retina. OCT provides cross-sectional images of blood vessel morphology by analyzing the interference patterns of near-infrared light refracted from the tissue. The micrometer-scale resolution of OCT is 10-times higher t ...
... Optical coherence tomography (OCT) was first demonstrated in 1991 for imaging the retina. OCT provides cross-sectional images of blood vessel morphology by analyzing the interference patterns of near-infrared light refracted from the tissue. The micrometer-scale resolution of OCT is 10-times higher t ...
Cardio Investigations - Ipswich-Year2-Med-PBL-Gp-2
... • The only absolute way to evaluate coronary artery disease is by angiography. It is usually performed as part of cardiac catheterisation, which includes left ventricular angiography and haemodynamic measurements, providing a more complete evaluation of an individual’s cardiac status. ...
... • The only absolute way to evaluate coronary artery disease is by angiography. It is usually performed as part of cardiac catheterisation, which includes left ventricular angiography and haemodynamic measurements, providing a more complete evaluation of an individual’s cardiac status. ...
- Science and Technology in Action (STA)
... releases a drug to prevent the over growth of cells on the artery wall. This prevents re-narrowing the artery after stent implantation. One of the first successful drug-eluting stents, called the Cypher® Stent, is produced by Cordis. This stent was approved for use in Europe in 2002. To date, it has ...
... releases a drug to prevent the over growth of cells on the artery wall. This prevents re-narrowing the artery after stent implantation. One of the first successful drug-eluting stents, called the Cypher® Stent, is produced by Cordis. This stent was approved for use in Europe in 2002. To date, it has ...
IV FD-CTA - Rackcdn.com
... stenosis or residual stenosis are not uncommon. • The standard imaging modality to follow up such intracranial stents is by performing conventional digital subtraction angiography (DSA) which is an invasive costly method and carries a low complication rate which can be serious. • A minimally invasiv ...
... stenosis or residual stenosis are not uncommon. • The standard imaging modality to follow up such intracranial stents is by performing conventional digital subtraction angiography (DSA) which is an invasive costly method and carries a low complication rate which can be serious. • A minimally invasiv ...
Coronary Artery Disease
... Clopidogrel 75 mg/d, at least 1 mo (Class I, A), ideally up to 1 yr (Class I, B) ...
... Clopidogrel 75 mg/d, at least 1 mo (Class I, A), ideally up to 1 yr (Class I, B) ...
Problémový okruh 5 (Dušnost a bolest na hrudi)
... monitor showed broad QRS complex tachycardia. Electrical cardioversion proceeded without delay with a short-term restoration of sinus rhythm. In a few seconds, tachycardia returned with fast deterioration to ventricular fibrillation. Defibrillation (300 J) and administration of Amiodarone 1 amp i.v. ...
... monitor showed broad QRS complex tachycardia. Electrical cardioversion proceeded without delay with a short-term restoration of sinus rhythm. In a few seconds, tachycardia returned with fast deterioration to ventricular fibrillation. Defibrillation (300 J) and administration of Amiodarone 1 amp i.v. ...
Drug-eluting stent
A drug-eluting stent (DES) is a peripheral or coronary stent (a scaffold) placed into narrowed, diseased peripheral or coronary arteries that slowly releases a drug to block cell proliferation. This prevents fibrosis that, together with clots (thrombi), could otherwise block the stented artery, a process called restenosis. The stent is usually placed within the peripheral or coronary artery by an interventional cardiologist or interventional radiologist during an angioplasty procedure.Drug-eluting stents in current clinical use were approved by the FDA after clinical trials showed they were statistically superior to bare-metal stents for the treatment of native coronary artery narrowings, having lower rates of major adverse cardiac events (usually defined as a composite clinical endpoint of death + myocardial infarction + repeat intervention because of restenosis). The first drug-eluting stents to be approved in Europe and the U.S. were coated with paclitaxel or an mTOR inhibitor, such as sirolimus.